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EFFECTS OF CHRONIC DIAZEPAM ON ABSENCE-LIKE 
PHENOMENA IN THE EEG OF THE WAG/Rij RAT
C,M van Rijn and M.L.A. Jongsma.
Psychology/NICI, University o f Nijmegen, P.O. Box 9104,
6500 HE Nijmegen, The Netherlands. Fax;+31.80.616066.
We evaluated the effects of chronic diazepam during 21 days on 
spike-wave discharges (SWD's) in the EEG of the WAG/Rij rat, 
an animal model for absence epilepsy.
The animals subcutaneously received silastic tubes either empty or 
filled with diazepam (50 mg/kg/day) resulting in constant blood 
concentrations (± 200 ng/ml), EEG's were recorded during 2 
hours. Two baselines were recorded. During the treatment we 
registered the EEG 5 times. A post-drug recording was taken 9 
days after tube removal.
In the control group a linear increase in the number of the SWD's 
was found (0.25/h/day), whereas the mean duration remained con­
stant. Diazepam reduced both the number and the duration of 
SWD's during the entire treatment. These effects gradually dimin­
ished during the treatment however. The number of SWD's could 
be described by a limited exponential growth (tw of 3 days) super­
posed on a linear increase (0.25/h/day) suggesting a fast partial 
loss of diazepam effect. The mean duration was described by a 
linear increase only (0.08 s/day) suggesting a gradual loss of the 
diazepam effect with a tw of about 20 days. On the post treatment 
measurement no group differences were found.
Tolerance develops to the anti-absence effect of diazepam, but dif­
ferent tw's were found for the frequency of the absences and their 
duration. This observation is in agreement with the hypothesis that 
different molecular mechanisms underlie the genesis and the 
termination of epileptic phenomena.
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Site directed mutagenesis of the 5-HT2C receptor: Identification 
o f  residues involved in ligand binding
N. J. Stam, P. Vanderheyden, J. Kelder, C. Van Aiebeek, D, Leysen 
NVOrganon, SDG, P.O. Box 20, 5340 BH Oss, Netherlands
In order to investigate the molecular basis for ligand binding to the 
human 5-HT2C receptor we have constructed a three-dimensional 
model for this receptor using the atomic coordinates of the structurally 
related bacteriorhodopsin as a template. To validate our model we 
used an approach in which we investigated the binding of several 
structurally related ligands on wild-type receptor and on a panel of 
mutant receptors in which single residues presumed to be involved in 
ligand binding were systematically mutated. To investigate the role of 
two conserved aromatic residues in TM6 (Phe 327 and Phe328 in 
ligand binding, these residues were substituted for alanines,
Additional mutations were performed for two serine residues in TM4 
(Seri 82 and Seri 86), and one in TM5 (Ser2I9). Wild-type and mutant 
receptors were stable expressed inNIH3T3 cells and characterized by 
saturation and competition binding assays with 5-HT and with a 
number of structurally related compounds as well with the antagonists 
mesulergine and mianserin. As proposed by our model, Phe327 
supports the electrostatic interaction between the protonated amine 
group of 5-HT and the carboxylate group o f the conserved Asp in 
TMR3. Phe328 seems to play a pivotal role in the binding of the 
aromatic ring of 5-HT and mesulergine, Seri 86 in TM4 has a small 
but significant contribution in the binding of most of the tested 
compounds. In contrast, our experiments did not support a role for the 
indole NH of 5-HT in binding.
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Perspectives and pitfalls of cloned receptors as tools for 
pharmacological studies
N. J. Stam, M. v. Triest, M. v. Loosbroek, F. Dijcks, P. Levering,
A. Garritsen
NV Organon, SDG, P. O. Box 20, 5340 BH Oss, Netherlands
One of the most fundamental advances in drug screening is the ability 
to express cloned human receptors in micro organisms or eukaryotic 
cells for pharmacological studies. Traditional receptor binding assays 
in animal tissue are hampered by the existence of multiple subtypes of 
a receptor, as well as possible species differences. Fermentor-scale cell 
cultures now allow the production of homogeneous preparations of a 
single human receptor for use in receptor binding studies. Cloned 
human receptors often couple to endogenously present signaling 
pathways in the host cell. This allows the measurement of second 
messenger pathways, thus providing a sensitive assay to determine the 
agonistic or antagonistic properties of ligands. However, our recent 
experience is that careful interpretation of data obtained using 
recombinant receptors is warranted as the system may have a number 
of pitfalls. For example, in a number of cases, high receptor densities 
have been shown to cause ligand-independent signaling which may 
not only affect cell morphology and proliferation, but may also 
change pharmacological parameters. Overexpression of the receptor 
may result in the activation of signaling pathways that not necessarily 
reflect the physiological situation. E.g. differences in G protein 
content between brain tissue and the host cells have been found. 
Overexpression of the receptor may also result in overestimation of 
potency (pEC50) and intrinsic efficacy. This phenomenon seems to 
depend on the receptor subtype and the host cell used. To get more 
insight into these processes we generated a panel of single cell clones 
expressing different amounts of 5-HT1A and 5-HT2C receptors. The 
present study deals a number of these issues.
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G-PROTEIN ACTIVATION OF CLONED HUMAN 
MUSCARINIC Ml AND M2 RECEPTORS EXPRESSED IN 
CHO CELLS
P.M.L. Vanderheyden* and N.J. Stam^
Dept, o f  Nvurophamacology* and Biotechnology*t yV. V, Organon, 
Postbus 20. 5340 BH, Oss, Netherlands
Human Ml and M2 muscarinic receptor were cloned and stably 
transfected in CHO-KI cells. For each receptor subtype a clone was 
selected with similar receptor density as measured by saturation 
binding of [^MJ-QNB. The pharmacological profile was confirmed 
by [3H]-QN13 displacement curves with reference antagonists and is 
in agreement with literature data.
High affinity binding of the aselective agonist l^Hj-OXOM binding 
(Kd=1.4 nM, Bmax=1.23 pmol/mg) to the M2 clone represented 
18% of the total reccptor population, whereas no such binding could 
be detected to the Ml clone. Agonist [-^HJ-QNB displacement 
curves to M2 receptors revealed the presence of high and low 
affinity sites, whereas [^H]-OXOM displacement curves were 
monophasic with Ki values corresponding with high affinity sites 
only. Agonist high affinity sites for M l receptors could hardly be 
detected.
Furthermore we measured the ability of agonists to increase the 
binding of [^sj-GTPyS, In case of the M2 receptor, the obtained 
EC50 values correlated with the Ki values for the agonist high 
affinity sites. Pertussis toxin pretreaUncnt of the cells impaired 
agonist high affinity binding as well as the increase of [35S]-GTPyS 
binding illustrating the functional coupling of M2 receptors to Gi- 
proteins. Dose respons curves of agonist M l receptor mediated 
increase of [^SJ-GTPyS binding were shallow. Interestingly these 
effects were partially blocked by pertussis toxin, indicating 
additional Gi-coupling of these receptors.
